• Explore /
  • Poster
  • / Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer.

Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer.

Abstract Video & Slides Poster

Authors

Elizabeth Moser

Elizabeth Charlotte Moser

Galera Therapeutics, Malvern, PA

Elizabeth Charlotte Moser , Sarah E. Hoffe , Jessica Frakes , Todd Anthony Aguilera , Mona Karim , Lauren Elizabeth Colbert , Shalini Moningi , Ching-Wei David Tzeng , Peter F. Thall , Shubham Pant , Manoop S. Bhutani , Melissa Brookes , Jon Holmlund , Joseph M. Herman , Cullen M. Taniguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT03340974

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS4670)

DOI

10.1200/JCO.2020.38.15_suppl.TPS4670

Abstract #

TPS4670

Poster Bd #

278

Abstract Disclosures

Similar Posters

First Author: Jon Holmlund

First Author: Deirdre Jill Cohen

Poster

2011 ASCO Annual Meeting

Fiducial-less stereotactic radiotherapy for early-stage lung cancer: Efficacy and toxicity evaluation.

Fiducial-less stereotactic radiotherapy for early-stage lung cancer: Efficacy and toxicity evaluation.

First Author: J. Bibault

First Author: Luca Faustino Valle